Red Abbey Venture Partners

Sam Eletr, PhD, Senior Advisor

Sam Eletr, PhD currently serves as the interim CEO of Population Genetics, Ltd., a seed stage company based in the UK. Also, he currently serves as a Director of Third Wave Technologies (a NASDAQ-listed, DNA-based, diagnostic products company), of Faust Pharmaceuticals, a biopharmaceutical company based in Strasbourg, France and of SpinX Technologies, a micro-fluidics company based in Geneva, Switzerland. Dr. Eletr also served as a Director of i-STAT, a point-of-care diagnostics company, from 2001 until its acquisition by Abbott Laboratories in December 2003 and as a Director of Solexa, Ltd, a genomics company based in Cambridge, England, from 2002 until July 2004.

From 1992 to 1999, Dr. Eletr served as Chairman of the Board of Lynx Therapeutics, a publicly traded genomics company. In late 1979, he co-founded Applied Biosystems, Inc. (now the Applied Biosystems Group of Applera Corporation), a developer and manufacturer of protein and DNA synthesis and sequencing instruments and reagents, where he served as Chairman and CEO from its founding until 1987. Prior to co-founding Applied Biosystems, he was Manager of an Analytical and Medical Instruments Group at the Hewlett-Packard corporate research laboratories in Palo Alto.

Dr. Eletr obtained an MA in Physics and a PhD in Biophysical Chemistry from the University of California at Berkeley. Prior to his MA, he studied Electrical Engineering at the Polytechnic Institute in Grenoble, France.

Return to the Scientific Advisory Board